What is Acute Lymphocytic Leukemia (ALL)?
Acute Lymphocytic Leukemia (ALL) is a fast-growing cancer of the blood and bone marrow that affects lymphoid cells, primarily immature white blood cells called lymphoblasts. It is the most common type of cancer in children but can also occur in adults.
Role of Stem Cell Therapy:
For high-risk or relapsed ALL, hematopoietic stem cell transplantation (HSCT) can be a life-saving treatment. The procedure replaces the patient’s diseased bone marrow with healthy stem cells, often from a donor, to restore normal blood cell production and immune function.
Medical Insight:
Allogeneic HSCT (from a matched donor) offers a curative option, especially for patients with poor prognostic markers or those who have relapsed after chemotherapy. The graft-versus-leukemia effect can help eliminate residual disease.
Source:
National Cancer Institute (NCI): https://www.cancer.gov/types/leukemia/patient/adult-all-treatment-pdq
Why consider stem cell storage for ALL?
Because ALL can progress quickly and finding a donor match takes time. Storing your child’s stem cells at birth ensures immediate access to a potential life-saving treatment.
